tumor

The study provides a more accurate tool for stratifying patients with HER2-positive breast cancer

The study provides a more accurate tool for stratifying patients with HER2-positive breast cancer

Patients with a type of breast cancer called HER2-positive have a lower chance of survival if their initial treatment fails to completely eradicate the tumor and they have high levels of tumor-infiltrating immune cells called lymphocytes in the residual disease. Dr Federica Miglietta said on the 13thThursday European Breast Cancer Conference that normally tumor-infiltrating lymphocytes …

The study provides a more accurate tool for stratifying patients with HER2-positive breast cancer Read More »

Integrating recent advances in multi-omic tumor profiling into precision cancer treatment

Integrating recent advances in multi-omic tumor profiling into precision cancer treatment

Tumors have significant differences depending on the person affected, even if they are the same cancer, such as breast cancer. Therefore, precision oncology focuses on the specific genetic characteristics of the tumor and incorporates them into the treatment. In this way, existing therapies can be “tailored” to avoid side effects and save money on expensive …

Integrating recent advances in multi-omic tumor profiling into precision cancer treatment Read More »

Liquid biopsy can save colon cancer patients from chemotherapy

Liquid biopsy can save colon cancer patients from chemotherapy

CHICAGO – Early colon cancer patients who have been found circulating tumor DNA in their blood may need more aggressive treatment, but people who have a negative liquid biopsy seem safe to avoid chemotherapy – without an increased risk of recurrence, the researchers suggested. . About 28% of patients diagnosed with stage II colon cancer …

Liquid biopsy can save colon cancer patients from chemotherapy Read More »

Expert: Circulating tumor DNA is a "hidden link" for monitoring colorectal and other cancers

Expert: Circulating tumor DNA is a “hidden link” for monitoring colorectal and other cancers

In an interview with Pharmacy Times Bruce Feinberg, DO, vice president and chief physician at Cardinal Health Specialty Solutions, discussed the use of circulating tumor DNA (ctDNA), its current use in colorectal cancer, and how it could be used in the future at the annual meeting of the American Society for Clinical Oncology (ASCO) 2022. …

Expert: Circulating tumor DNA is a “hidden link” for monitoring colorectal and other cancers Read More »